Antipsychotic Medication During the Critical Period Following Remission From First-Episode Psychosis
- 1 September 2013
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 70 (9) , 898-900
Abstract
The person recovering from a first episode of psychosis (FEP), the family, and the treating clinical team have until now faced a real dilemma. Having reached thKeywords
This publication has 9 references indexed in Scilit:
- On the HORYZON: Moderated online social therapy for long-term recovery in first episode psychosisSchizophrenia Research, 2013
- Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studiesSchizophrenia Research, 2012
- Treatment response after relapse in a placebo-controlled maintenance trial in schizophreniaSchizophrenia Research, 2012
- A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients: Outcome at 30-Month Follow-UpSchizophrenia Bulletin, 2011
- Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 yearsPsychological Medicine, 2011
- Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trialBMJ, 2010
- Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early interventionSchizophrenia Research, 2010
- Vocational intervention in first-episode psychosis: Individual placement and support v. treatment as usualThe British Journal of Psychiatry, 2008
- Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset SchizophreniaAmerican Journal of Psychiatry, 2001